reach semaglutide Patients come to Ro to their health goals—and our study in Obesity (@ObesitySociety) shows that they're successful. Weight loss and safety outcomes were consistent with those in clinical trials, losing ACHIEVE-3: Orforglipron Superior to Semaglutide
Description
We're here to helpyour satisfaction is our top priority!
Comorbidities such as cardiovascular disease, sleep apnea, or uncontrolled diabetes change priorities: reduce hypoglycemia risk, avoid volume depletion, and maintain glycemic targets that fit the procedures risk profile

I knowthats probably not what you were hoping to hear

Gastrointestinal Concerns : Worsening of nausea, vomiting, or other side effects of Semaglutide
/assets/images/provider/photos/2789240.jpg)
Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed for weight management in UK adults with BMI 30 kg/m or 27 kg/m with comorbidities

If you're currently on the Ro Body Program and considering a switch, or if you're just starting your weight loss journey and want the most honest, transparent pricing available, Losing Weight RX is the clear value leader in 2026